2025-2034 Growth Prospects of the Uterine Fibroid Embolization Device Market: Key Trends and Opportunities Analyzed
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Uterine Fibroid Embolization Device Market from 2025 to 2034, and What Factors Influence It?
In the past few years, there has been a robust growth in the market size of uterine fibroid embolization devices. It is set to increase from $5.62 billion in 2024 to $5.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The historical growth is owed to the escalating incidence of uterine fibroids, inclination towards non-surgical alternatives, awareness campaigns and educational initiatives, emphasis on women’s health, shift towards outpatient proceedings, and physician training programs.
The market for uterine fibroid embolization devices is projected to experience consistent growth in the coming years, reaching an estimated size of $7.04 billion by 2029, with a compound annual growth rate (CAGR) of 4.4%. Increased knowledge of non-invasive therapies, advancement of healthcare services worldwide, emphasis on women’s healthcare, combination with multidisciplinary care, and growth of outpatient services are key factors contributing to the predicted growth during this period. Major trends to look out for include rising preference for minimally invasive procedures, development of embolic agents, personalized treatment strategies, prioritizing outpatient UFE processes, incorporation of imaging technology, and research around bioresorbable embolic agents.
Which Primary Drivers Are Supporting the Continued Expansion of the Uterine Fibroid Embolization Device Market?
The burgeoning need for less invasive medical procedures is set to accelerate the growth of the uterine fibroid embolization device market. These less invasive surgical methods use tiny incisions or body openings to reach and treat internal organs, structures, or tissues, causing less damage to the patient’s body. Uterine fibroid embolization devices have a crucial role in facilitating these less invasive surgeries, treating uterine fibroids efficiently. These uniquely designed devices aim to lessen invasiveness through tiny incisions, thereby reducing the effects on nearby tissues. They are designed to meet the rising demand for surgical procedures that are less invasive, consequently enhancing patient outcomes. For example, The Aesthetic Society, an American organization of plastic surgery and cosmetic medicine, declared in August 2023 that expenditure on aesthetic procedures in the US was more than $11.8 billion, experiencing an increase of 2% compared to the previous year. Hence, the surging demand for less invasive surgeries stimulates the uterine fibroid embolization device market’s growth.
Uterine Fibroid Embolization Device Market Driver: Increase in Aged Population Boosts Growth in Uterine Fibroid Embolization Devices Market
Request Your Free Uterine Fibroid Embolization Device Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13551&type=smp
Who Are the Key Market Players Influencing the Growth of the Uterine Fibroid Embolization Device Industry?
Major companies operating in the uterine fibroid embolization device market report are:
• Johnson and Johnson Pvt Ltd._x000D_
• Abbott Laboratories_x000D_
• Medtronic plc._x000D_
• Siemens Healthineers Ltd._x000D_
• Koninklijke Philips N.V._x000D_
What Are the Most Significant Trends Transforming the Uterine Fibroid Embolization Device Market Today?
A leading player in the uterine fibroid embolization device market, Medtronic Private Limited, an India-based healthcare technology company, launched an innovative product called the TruClear system in November 2022. This new invention was designed to meet the escalating demand for less invasive procedures in the treatment of uterine fibroids, enhancing both the safety and effectiveness of these treatments. The TruClear system works as a mechanical hysteroscopic tissue removal device, aiming to treat intrauterine abnormalities (IUA). This tool is introduced into the uterus via the cervix and is distinguished by its compact nature and flexibility. The inclusion of a rotating nitinol wire loop, consistent inflow and outflow, inbuilt suction, and high-resolution imaging further enhances the precision and safety of the treatment methods for uterine fibroids.
Pre-order Your Report for Quick and Easy Delivery!
How Are the Key Segments of the Uterine Fibroid Embolization Device Market Impacting Its Expansion and Revenue Streams?
The uterine fibroid embolization device market covered in this report is segmented –
1) By Technology: Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
2) By Mode Of Treatment: Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment
3) By End User: Hospitals, Clinics, Ambulatory Surgical Center
Subsegments:
1) By Surgical Techniques: Open Surgery, Myomectomy
2) By Laparoscopic Techniques: Laparoscopic Myomectomy, Laparoscopic Hysterectomy
3) By Ablation Techniques: Radiofrequency Ablation, Microwave Ablation, Cryoablation
4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE), Uterine Artery Embolization (UAE)
Which Geographical Regions Are Shaping the Uterine Fibroid Embolization Device Market Growth?
North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Aspects of the Uterine Fibroid Embolization Device Market Landscape?
A uterine fibroid embolization device is a medical device that is used to treat noncancerous tumors using a minimally invasive process. Uterine fibroids are noncancerous growths of the uterus. This device restricts blood supply to uterine fibroids, causing them to shrink and eventually disappear.
Browse Through More Similar Reports By The Business Research Company:
Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2024
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Lancing Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: